Trademark: 86614951
Word
KANDAVE
Status
Dead
Status Code
710
Status Date
Friday, May 13, 2022
Serial Number
86614951
Registration Number
4846065
Registration Date
Tuesday, November 3, 2015
Mark Type
4000
Filing Date
Thursday, April 30, 2015
Published for Opposition
Tuesday, August 18, 2015
Cancellation Date
Friday, May 13, 2022

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
KAN DAVE: CAN DAVE

Trademark Events
May 13, 2022
Cancelled Sec. 8 (6-Yr)
Nov 3, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Feb 14, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 14, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 3, 2015
Registered-Principal Register
Aug 18, 2015
Official Gazette Publication Confirmation E-Mailed
Aug 18, 2015
Published For Opposition
Jul 29, 2015
Notification Of Notice Of Publication E-Mailed
Jul 1, 2015
Approved For Pub - Principal Register
Jun 30, 2015
Assigned To Examiner
Jun 23, 2015
Teas Change Of Correspondence Received
May 12, 2015
Notice Of Pseudo Mark E-Mailed
May 11, 2015
New Application Office Supplied Data Entered In Tram
May 4, 2015
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24